Výsledky vyhledávání

Akademický článek

Changes of bone turnover markers and bone mineral density among postmenopausal Thai women with osteoporosis receiving generic risedronate.

Autor: Suwan, Ammarin^1,2 (AUTHOR), Tanavalee, Chotetawan^3,4 (AUTHOR) tanavalee.chote@gmail.com, Panyakhamlerd, Krasean^1,2 (AUTHOR), Ngarmukos, Srihatach^3,4 (AUTHOR), Chavaengkiat, Suchanant¹ (AUTHOR), Tanavalee, Aree^3,4 (AUTHOR), Amarase, Chavarin^3,4 (AUTHOR), Bumphenkiatikul, Thanapob^2,5 (AUTHOR)

Publikováno v: BMC Women's Health. 10/26/2024, Vol. 24 Issue 1, p1-9. 9p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Risedronate prevents exercise-induced hypercalcemia but not nausea or vomit in humans: a double blind randomized controlled trial.

Autor: Senda, Masamitsu^1,2 (AUTHOR), Fujii, Naohiko³ (AUTHOR), Ito, Toshimitsu² (AUTHOR), Isaka, Yoshitaka⁴ (AUTHOR), Moriyama, Toshiki¹ (AUTHOR), Hamano, Takayuki^4,5 (AUTHOR) hamatea@med.nagoya-cu.ac.jp

Publikováno v: Scientific Reports. 9/28/2024, Vol. 14 Issue 1, p1-10. 10p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Effects of a locally administered risedronate/autogenous bone graft combination on bone healing in a critical-size rabbit defect model.

Autor: Özer, Taha¹ taha.ozer@gmail.com, Guliyeva, Vusala¹, Aktaş, Alper¹, Barış, Emre², Ocak, Mert³

Publikováno v: Journal of Orthopaedic Surgery & Research. 2/4/2023, Vol. 18 Issue 1, p1-11. 11p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Changes of bone turnover markers and bone mineral density among postmenopausal Thai women with osteoporosis receiving generic risedronate

Autor: Ammarin Suwan, Chotetawan Tanavalee, Krasean Panyakhamlerd, Srihatach Ngarmukos, Suchanant Chavaengkiat, Aree Tanavalee, Chavarin Amarase, Thanapob Bumphenkiatikul

Publikováno v: BMC Women's Health, Vol 24, Iss 1, Pp 1-9 (2024)

Abstract Background Osteoporosis has been recognized as a significant health issue in Thailand. Pharmacological interventions are important way to prevent fracture. However, one of the main challenges in selecting a medication is high cost, particula

Externí odkaz: https://doaj.org/article/7a6d222fd34e406cb1843329dec13b03

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Effectiveness of Short-Term Use Denosumab and Risedronate Using β-Crosslaps and Histopathology as a Parameter in Osteoporotic Rat Model

Autor: Afrisya Bimo Siwendro, Ahmad Ramdan, Yoyos Dias Ismiarto, Anglita Yantisetiasti, Dliyauddin fachri

Publikováno v: Majalah Kedokteran Bandung, Vol 56, Iss 3, Pp 197-202 (2024)

Osteoporosis is a condition of decreased bone mass density. Pharmacological management uses drugs that decrease bone resorption or increase bone formation. The most commonly used drugs are bisphosphonates. Risedronate is one of these bisphosphonates.

Externí odkaz: https://doaj.org/article/ebc60b8a4e114663a35aadc544ca5bce

Zobrazit plný text záznamu

Akademický článek

Gelatin–Zinc Carrier as a New Method of Targeted and Controlled Release of Risedronate.

Autor: Reczkowski, Jakub¹ (AUTHOR) jakub.reczkowski@student.put.poznan.pl, Długosz, Maria¹ (AUTHOR) maria.dlugosz.pl@gmail.com, Ratajczak, Maria² (AUTHOR) maria.ratajczak@put.poznan.pl, Voelkel, Adam¹ (AUTHOR) adam.voelkel@put.poznan.pl, Sandomierski, Mariusz¹ (AUTHOR) mariusz.sandomierski@put.poznan.pl

Publikováno v: Materials (1996-1944). Jun2024, Vol. 17 Issue 11, p2473. 15p.

Zobrazit plný text záznamu

Plný text ve formátu HTML